CXCL1 and neoplasm: This receptor guides myeloid-derived cells from the bone marrow to CXCL1-overexpressing tumor sites, where they facilitate tumor immune evasion by suppressing the proliferation, activation, and motility of effector T cells and promoting the numerical expansion of Tregs [41, 42].